198 related articles for article (PubMed ID: 22530837)
1. Mitochondrial targeting for development of novel drug strategies in brain injury.
Soustiel JF; Zaaroor M
Cent Nerv Syst Agents Med Chem; 2012 Jun; 12(2):131-45. PubMed ID: 22530837
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the mitochondrial benzodiazepine receptor in traumatic brain injury: therapeutic implications.
Vlodavsky E; Palzur E; Soustiel JF
CNS Neurol Disord Drug Targets; 2014; 13(4):620-9. PubMed ID: 24168365
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial biology, targets, and drug delivery.
Milane L; Trivedi M; Singh A; Talekar M; Amiji M
J Control Release; 2015 Jun; 207():40-58. PubMed ID: 25841699
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial uncoupling as a therapeutic target following neuronal injury.
Sullivan PG; Springer JE; Hall ED; Scheff SW
J Bioenerg Biomembr; 2004 Aug; 36(4):353-6. PubMed ID: 15377871
[TBL] [Abstract][Full Text] [Related]
5. Reversible Disruption of Neuronal Mitochondria by Ischemic and Traumatic Injury Revealed by Quantitative Two-Photon Imaging in the Neocortex of Anesthetized Mice.
Kislin M; Sword J; Fomitcheva IV; Croom D; Pryazhnikov E; Lihavainen E; Toptunov D; Rauvala H; Ribeiro AS; Khiroug L; Kirov SA
J Neurosci; 2017 Jan; 37(2):333-348. PubMed ID: 28077713
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury.
Sullivan PG; Thompson MB; Scheff SW
Exp Neurol; 1999 Nov; 160(1):226-34. PubMed ID: 10630207
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial dysfunction after experimental and human brain injury and its possible reversal with a selective N-type calcium channel antagonist (SNX-111).
Verweij BH; Muizelaar JP; Vinas FC; Peterson PL; Xiong Y; Lee CP
Neurol Res; 1997 Jun; 19(3):334-9. PubMed ID: 9192388
[TBL] [Abstract][Full Text] [Related]
8. Targeting mitochondrial dysfunction in CNS injury using Methylene Blue; still a magic bullet?
Vekaria HJ; Talley Watts L; Lin AL; Sullivan PG
Neurochem Int; 2017 Oct; 109():117-125. PubMed ID: 28396091
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial damage: a target for new therapeutic horizons.
Soustiel JF; Larisch S
Neurotherapeutics; 2010 Jan; 7(1):13-21. PubMed ID: 20129493
[TBL] [Abstract][Full Text] [Related]
10. The optimal dosage and window of opportunity to maintain mitochondrial homeostasis following traumatic brain injury using the uncoupler FCCP.
Pandya JD; Pauly JR; Sullivan PG
Exp Neurol; 2009 Aug; 218(2):381-9. PubMed ID: 19477175
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria in traumatic brain injury and mitochondrial-targeted multipotential therapeutic strategies.
Cheng G; Kong RH; Zhang LM; Zhang JN
Br J Pharmacol; 2012 Oct; 167(4):699-719. PubMed ID: 23003569
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial participation in ischemic and traumatic neural cell death.
Fiskum G
J Neurotrauma; 2000 Oct; 17(10):843-55. PubMed ID: 11063052
[TBL] [Abstract][Full Text] [Related]
13. Post-Injury Administration of Mitochondrial Uncouplers Increases Tissue Sparing and Improves Behavioral Outcome following Traumatic Brain Injury in Rodents.
Pandya JD; Pauly JR; Nukala VN; Sebastian AH; Day KM; Korde AS; Maragos WF; Hall ED; Sullivan PG
J Neurotrauma; 2007 May; 24(5):798-811. PubMed ID: 17518535
[TBL] [Abstract][Full Text] [Related]
14. Targeting mitochondrial function for the treatment of breast cancer.
Deus CM; Coelho AR; Serafim TL; Oliveira PJ
Future Med Chem; 2014 Sep; 6(13):1499-513. PubMed ID: 25365234
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
16. Targeting mitochondria.
Hoye AT; Davoren JE; Wipf P; Fink MP; Kagan VE
Acc Chem Res; 2008 Jan; 41(1):87-97. PubMed ID: 18193822
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial dysfunction contributes to cell death following traumatic brain injury in adult and immature animals.
Robertson CL
J Bioenerg Biomembr; 2004 Aug; 36(4):363-8. PubMed ID: 15377873
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial uncoupling as a potential therapeutic target in acute central nervous system injury.
Maragos WF; Korde AS
J Neurochem; 2004 Oct; 91(2):257-62. PubMed ID: 15447659
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death?
Sullivan PG; Rabchevsky AG; Waldmeier PC; Springer JE
J Neurosci Res; 2005 Jan 1-15; 79(1-2):231-9. PubMed ID: 15573402
[TBL] [Abstract][Full Text] [Related]
20. Targeting ischemic brain injury with intravenous immunoglobulin.
Arumugam TV; Selvaraj PK; Woodruff TM; Mattson MP
Expert Opin Ther Targets; 2008 Jan; 12(1):19-29. PubMed ID: 18076367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
